HIS
RLAY icon

Harvest Investment Services’s Relay Therapeutics RLAY Stock Holding History

Harvest Investment Services’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
+41,394
New +$601K 0.12% 183

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Harvest Investment Services's RLAY Position: Q2 2026 in Review

Harvest Investment Services opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 41,394 shares worth $774K. The stake represents 0.12% of the portfolio and ranks #183 among its holdings.

258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Harvest Investment Services held 41,394 shares of Relay Therapeutics worth $774K as of Q2 2026.
  • Relay Therapeutics was a new Harvest Investment Services position in Q2 2026.
  • Relay Therapeutics made up 0.12% of Harvest Investment Services's portfolio in Q2 2026, its #183 holding.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Harvest Investment Services's 13F filing for Q2 2026, filed 14 Aug 2026.